Lantheus Holdings, Inc. Lessee, Operating Lease, Liability, to be Paid
Lantheus Holdings, Inc. (LNTH) had Lessee, Operating Lease, Liability, to be Paid of $86.15 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-02-26
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $86.15M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $94.90M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $99.53M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $33.72M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2025-12-31 | $86.15M 10-K · filed 2026-02-26 |
| 2024-12-31 | $94.90M 10-K · filed 2025-02-26 |
| 2023-12-31 | $99.53M 10-K · filed 2024-02-22 |
| 2022-12-31 | $33.72M 10-K · filed 2023-02-23 |
| 2021-12-31 | $21.99M 10-K · filed 2022-02-24 |
| 2020-12-31 | $23.24M 10-K · filed 2021-02-25 |
| 2019-12-31 | $1.13M 10-K · filed 2020-02-25 |
| 2019-09-30 | $1.19M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $1.25M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $1.30M 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |